EPA attenuates epithelial-mesenchymal transition and fibrosis through the TGF-β1/Smad3/ILK pathway in renal tubular epithelial HK-2 cells by up-regulating miR-541

被引:1
|
作者
Wei, Zhiqiang [1 ]
Cao, Juan [2 ]
Zhang, Xu [2 ]
Yin, Di [2 ]
Xu, Deyu [1 ]
Lu, Guoyuan [1 ]
机构
[1] Soochow Univ, Dept Nephrol, Affiliated Hosp 1, Shizi St 188, Suzhou, Peoples R China
[2] Yangzhou Univ, Dept Nephrol, Affiliated Taixing Peoples Hosp, Taixing, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2019年 / 12卷 / 07期
关键词
EPA; Alb; miR-541; EMT; renal fibrosis; TGF-beta 1/Smad3/ILK signaling pathway; EICOSAPENTAENOIC ACID; INDUCED INFLAMMATION; MICRORNAS; INJURY; PROLIFERATION; NEPHROPATHY; EXPRESSION; MECHANISM; PROTECTS; DISEASE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It was reported that eicosapentaenoic acid (EPA) could prevent tubulointerstitial injury in kidney. EPA could also inhibit the epithelial-mesenchymal transition (EMT) of HK-2 cells stimulated by albumin (Alb) in vitro. However, the regulating molecular mechanism of EPA remains to be elucidated. Methods: An immortalized human proximal tubular cell line (human kidney-2 (HK-2) cells) was used in all experiments. MTT assay was employed to determine the effect of Alb or EPA on the cell viability of HK-2 cells. The miR-541 expression, the mRNA levels of EMT markers E-cadherin, alpha-smooth muscle actin (alpha-SMA), and fibrogenesis markers Collagen I and fibronectin (FN) were examined by RT-qPCR assay. The protein levels of E-cadherin, alpha-SMA and Collagen I, transforming growth factor (TGF-beta 1)/Smad3/integrin-linked kinase (ILK) pathway-related protein TGF-beta 1, pSmad2/3, Smad7 and ILK were measured by western blot. Enzyme-linked immunosorbent assay (ELISA) was performed to detect FN expression. The target relationship between miR-541 and TGF-beta 1 was confirmed by bioinformatics, luciferase reporter assay and western blot. Results: Low doses of Alb had no effect on the cell viability of HK-2 cells, while EPA repressed the cell viability of HK-2 cells in a concentration-dependent manner. EPA could inhibit EMT and fibrosis and increase the miR-541 expression of HK-2 cells exposed to Alb. Interestingly, introduction of miR-541 effectively abolished the EMT and fibrosis of HK-2 cells stimulated by Alb. Bioinformatics analysis predicted TGF-beta 1 as a target gene of miR-541, and subsequent luciferase reporter assay and western blot further supported the prediction. miR-541 counter-regulated TGF-beta 1 expression, and inhibited the TGF-beta 1/Smad3/ILK pathway. Alb treatment activated the TGF-beta 1/ Smad3/ILK pathway, while EPA inhibited the activation of the pathway. miR-541 inhibitors reversed the effects of EPA on EMT, fibrosis, and TGF-beta 1/Smad3/ILK pathway-related protein expression induced by Alb. Conclusion: EPA attenuates EMT and renal fibrosis through the TGF-beta 1/Smad3/ILK pathway in renal epithelial cells by targeting miR-541.
引用
收藏
页码:2516 / 2525
页数:10
相关论文
共 50 条
  • [1] Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells
    Bae, Eunjin
    Kim, Seong-Jin
    Hong, Suntaek
    Liu, Fang
    Ooshima, Akira
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 427 (03) : 593 - 599
  • [2] NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
    Jin, Zhibo
    Gu, Chaohui
    Tian, Fengyan
    Jia, Zhankui
    Yang, Jinjian
    CELL AND TISSUE RESEARCH, 2017, 369 (03) : 603 - 610
  • [3] NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
    Zhibo Jin
    Chaohui Gu
    Fengyan Tian
    Zhankui Jia
    Jinjian Yang
    Cell and Tissue Research, 2017, 369 : 603 - 610
  • [4] Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway
    Fan, Qiong
    Qiu, Met-Ting
    Zhu, Zhu
    Zhou, Jin-Hua
    Chen, Limo
    Zhou, Ye
    Gu, Wei
    Wang, Li-Hua
    L, Zhu-Nan, I
    Xu, Ying
    Cheng, Wei-Wei
    Wu, Dan
    Bao, Wei
    ONCOLOGY REPORTS, 2015, 34 (04) : 1787 - 1794
  • [5] ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway
    Li, M.
    Zhou, H.
    Di, J.
    Yang, M.
    Jia, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (01) : 289 - 296
  • [6] Sirtuin 6 attenuates epithelial-mesenchymal transition by suppressing the TGF-β1/Smad3 pathway and c-Jun in asthma models
    Liu, Fen
    Shang, Yun-Xiao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 82
  • [7] Heptachlor-induced epithelial to mesenchymal transition in HK-2 cells mediated via TGF-β1/Smad signalling
    Singh, N.
    Siddarth, M.
    Ghosh, R.
    Tripathi, A. K.
    Banerjee, B. D.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (05) : 567 - 577
  • [8] AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
    Liming Deng
    Wenming Bao
    Baofu Zhang
    Sina Zhang
    Ziyan Chen
    Xuewen Zhu
    Bangjie He
    Lijun Wu
    Xiaohu Chen
    Tuo Deng
    Bo Chen
    Zhengping Yu
    Yi Wang
    Gang Chen
    Cell Death & Disease, 14
  • [9] Ginkgobiloba leaf extract mitigates cisplatin-induced chronic renal interstitial fibrosis by inhibiting the epithelial-mesenchymal transition of renal tubular epithelial cells mediated by the Smad3/TGF-β1 and Smad3/p38 MAPK pathways
    Congying Wei
    Yansong Zhang
    Xiaobin Zhong
    Sisi Lu
    Xiaoqin Zou
    Yufang Yang
    Songqing Huang
    Zhenguang Huang
    Chinese Medicine, 17
  • [10] AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
    Deng, Liming
    Bao, Wenming
    Zhang, Baofu
    Zhang, Sina
    Chen, Ziyan
    Zhu, Xuewen
    He, Bangjie
    Wu, Lijun
    Chen, Xiaohu
    Deng, Tuo
    Chen, Bo
    Yu, Zhengping
    Wang, Yi
    Chen, Gang
    CELL DEATH & DISEASE, 2023, 14 (09)